下面的时坛干将可以上网了解一下,不要信口开河。

这是以色列的study.

CONCLUSIONS

Among patients 65 years of age or older, the rates of hospitalization and death due to Covid-19 were significantly lower among those who received nirmatrelvir than among those who did not. No evidence of benefit was found in younger adults.

https://www.nejm.org/doi/full/10.1056/NEJMoa2204919

 

所有跟帖: 

这个我已经揭穿过它的骗术了 -blueberry01- 给 blueberry01 发送悄悄话 blueberry01 的博客首页 (720 bytes) () 01/18/2023 postreply 22:14:53

40-64岁组,服用P药住院率每十万人只降低0.6人,死亡率增加32%。你还推销? -blueberry01- 给 blueberry01 发送悄悄话 blueberry01 的博客首页 (574 bytes) () 01/18/2023 postreply 22:24:38

No evidence of benefit was found in younger adults. -goingunder- 给 goingunder 发送悄悄话 (4756 bytes) () 01/18/2023 postreply 22:43:30

对于年轻组,为什么掩饰no evidence? 明明服P药死亡率更高 -blueberry01- 给 blueberry01 发送悄悄话 blueberry01 的博客首页 (66 bytes) () 01/19/2023 postreply 00:44:06

请您先登陆,再发跟帖!